Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
KROS
Stock Latest News
Market News
3 Best Stocks to Buy Now, 3/17/2025, According to Top Analysts
14d ago
MU
APP
Premium
Ratings
Buy Rating for Keros Therapeutics: Promising Potential of KER-065 Amidst Investor Concerns
17d ago
KROS
Premium
Company Announcements
Keros Therapeutics CEO to Speak at Major Conferences
1M ago
8K
KROS
Premium
Ratings
Keros Therapeutics Hold Rating: Uncertainty in KER-065 Development and Cibotercept Safety Concerns
1M ago
KROS
Premium
Company Announcements
Keros Therapeutics Strengthens Financial Position Amid R&D Expansion
1M ago
KROS
Premium
The Fly
Keros Therapeutics reports Q4 EPS ($1.14) vs. ($1.34) last year
1M ago
KROS
Premium
Company Announcements
Keros Therapeutics CEO to Speak at Biotech Conference
2M ago
8K
KROS
Premium
The Fly
Keros Therapeutics announces effectiveness of global agreement with Takeda
2M ago
TAK
KROS
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago
KROS
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ANIX
ERNA
Premium
The Fly
Keros Therapeutics downgraded at Wedbush after removing PAH, obesity programs
2M ago
KROS
Premium
The Fly
Keros Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $15 from $40 at Piper Sandler
2M ago
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
2M ago
TAK
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $23 from $63 at Oppenheimer
2M ago
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $32 from $33 at BofA
2M ago
KROS
Premium
The Fly
Big banks report Q4 beats, QXO proposes to buy Beacon: Morning Buzz
2M ago
C
S
Premium
The Fly
Morning Movers: Wells Fargo and Citi gain following Q4 earnings
2M ago
C
BK
Premium
The Fly
Keros Therapeutics voluntarily halts all dosing of Phase 2 TROPOS trial
2M ago
KROS
Premium
Company Announcements
Keros Therapeutics Updates on Clinical Trials and Safety
3M ago
8K
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $43 from $100 at Truist
3M ago
TAK
KROS
Premium
The Fly
Keros Therapeutics price target lowered to $63 from $102 at Oppenheimer
3M ago
KROS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
